Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07557225
NA

18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors

Sponsor: Peking University First Hospital

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to evaluate the diagnostic value of CAIX protein specific probe 18F-T2 in PET/CT imaging in participants with solid tumors. It will also assess the safety, tolerability and radiation dosimetry of 18F-T2.

Official title: Evaluation of Diagnostic Value of 18F-T2 PET/ CT Imaging for Tumors Likely to Express High Levels of CAIX

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

200

Start Date

2026-04

Completion Date

2029-03

Last Updated

2026-04-29

Healthy Volunteers

Yes

Interventions

DIAGNOSTIC_TEST

18F-T2 PET/CT

18F-T2 is injected intravenously with a dose of 0.05-0.10 mCi/kg. The CT and PET imaging session will begin approximately 60 minutes after 18F-T2 administration.

Locations (1)

Peking University First Hospital

Beijing, Beijing Municipality, China